25 XP   0   0   10

Pure Bioscience Inc
Buy, Hold or Sell?

Let's analyse Pure Bioscience Inc together

PenkeI guess you are interested in Pure Bioscience Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Pure Bioscience Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Pure Bioscience Inc

I send you an email if I find something interesting about Pure Bioscience Inc.

Quick analysis of Pure Bioscience Inc (30 sec.)










What can you expect buying and holding a share of Pure Bioscience Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.01
Expected worth in 1 year
$-0.04
How sure are you?
35.0%

+ What do you gain per year?

Total Gains per Share
$-0.03
Return On Investment
-43.3%

For what price can you sell your share?

Current Price per Share
$0.07
Expected price per share
$0.06 - $0.07
How sure are you?
50%

1. Valuation of Pure Bioscience Inc (5 min.)




Live pricePrice per Share (EOD)

$0.07

Intrinsic Value Per Share

$-0.32 - $-0.38

Total Value Per Share

$-0.33 - $-0.39

2. Growth of Pure Bioscience Inc (5 min.)




Is Pure Bioscience Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.3m$2.6m-$2.6m-6,057.1%

How much money is Pure Bioscience Inc making?

Current yearPrevious yearGrowGrow %
Making money-$911.2k-$1m$100.2k11.0%
Net Profit Margin-199.0%-230.5%--

How much money comes from the company's main activities?

3. Financial Health of Pure Bioscience Inc (5 min.)




4. Comparing to competitors in the Household & Personal Products industry (5 min.)




  Industry Rankings (Household & Personal Products)  


Richest
#179 / 184

Most Revenue
#177 / 184

Most Profit
#146 / 184

Most Efficient
#178 / 184

What can you expect buying and holding a share of Pure Bioscience Inc? (5 min.)

Welcome investor! Pure Bioscience Inc's management wants to use your money to grow the business. In return you get a share of Pure Bioscience Inc.

What can you expect buying and holding a share of Pure Bioscience Inc?

First you should know what it really means to hold a share of Pure Bioscience Inc. And how you can make/lose money.

Speculation

The Price per Share of Pure Bioscience Inc is $0.07. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Pure Bioscience Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Pure Bioscience Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.01. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Pure Bioscience Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-12.8%-0.01-11.6%-0.01-12.9%-0.01-9.1%-0.01-17.0%
Usd Book Value Change Per Share-0.01-12.0%-0.01-10.8%0.00-0.4%0.00-1.6%0.00-0.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-12.0%-0.01-10.8%0.00-0.4%0.00-1.6%0.00-0.7%
Usd Price Per Share0.11-0.09-0.17-0.41-0.65-
Price to Earnings Ratio-3.07--2.86--4.75--15.10-13.42-
Price-to-Total Gains Ratio-13.12--12.35--14.20-349.80-172.45-
Price to Book Ratio-9.31-3.09-7.81-18.16-197.16-
Price-to-Total Gains Ratio-13.12--12.35--14.20-349.80-172.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.07
Number of shares14285
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (14285 shares)-108.17-15.57
Gains per Year (14285 shares)-432.68-62.27
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-433-4430-62-72
20-865-8760-125-134
30-1298-13090-187-196
40-1731-17420-249-258
50-2163-21750-311-320
60-2596-26080-374-382
70-3029-30410-436-444
80-3461-34740-498-506
90-3894-39070-560-568
100-4327-43400-623-630

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%2.018.00.010.0%3.034.03.07.5%4.036.057.04.1%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%7.013.00.035.0%14.026.00.035.0%32.065.00.033.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.097.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%7.013.00.035.0%14.026.00.035.0%32.065.00.033.0%

Fundamentals of Pure Bioscience Inc

About Pure Bioscience Inc

PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.

Fundamental data was last updated by Penke on 2024-04-24 16:29:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Pure Bioscience Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Pure Bioscience Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • A Net Profit Margin of -307.4% means that $-3.07 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Pure Bioscience Inc:

  • The MRQ is -307.4%. The company is making a huge loss. -2
  • The TTM is -199.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-307.4%TTM-199.0%-108.4%
TTM-199.0%YOY-230.5%+31.6%
TTM-199.0%5Y-175.2%-23.7%
5Y-175.2%10Y-501.9%+326.7%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-307.4%4.2%-311.6%
TTM-199.0%4.5%-203.5%
YOY-230.5%4.8%-235.3%
5Y-175.2%5.0%-180.2%
10Y-501.9%6.1%-508.0%
1.1.2. Return on Assets

Shows how efficient Pure Bioscience Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • -92.3% Return on Assets means that Pure Bioscience Inc generated $-0.92 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Pure Bioscience Inc:

  • The MRQ is -92.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -57.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-92.3%TTM-57.4%-34.9%
TTM-57.4%YOY-33.0%-24.3%
TTM-57.4%5Y-33.7%-23.7%
5Y-33.7%10Y-38.5%+4.8%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-92.3%1.4%-93.7%
TTM-57.4%1.5%-58.9%
YOY-33.0%1.6%-34.6%
5Y-33.7%1.9%-35.6%
10Y-38.5%2.2%-40.7%
1.1.3. Return on Equity

Shows how efficient Pure Bioscience Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • 0.0% Return on Equity means Pure Bioscience Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Pure Bioscience Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-112.3%+112.3%
TTM-112.3%YOY-41.1%-71.2%
TTM-112.3%5Y-54.4%-57.9%
5Y-54.4%10Y-85.2%+30.8%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.0%-3.0%
TTM-112.3%3.1%-115.4%
YOY-41.1%3.2%-44.3%
5Y-54.4%3.6%-58.0%
10Y-85.2%4.1%-89.3%

1.2. Operating Efficiency of Pure Bioscience Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Pure Bioscience Inc is operating .

  • Measures how much profit Pure Bioscience Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Pure Bioscience Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-53.7%+53.7%
TTM-53.7%YOY-211.7%+157.9%
TTM-53.7%5Y-135.0%+81.2%
5Y-135.0%10Y-478.2%+343.2%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.3%-7.3%
TTM-53.7%4.9%-58.6%
YOY-211.7%7.3%-219.0%
5Y-135.0%7.4%-142.4%
10Y-478.2%8.5%-486.7%
1.2.2. Operating Ratio

Measures how efficient Pure Bioscience Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Household & Personal Products industry mean).
  • An Operation Ratio of 4.41 means that the operating costs are $4.41 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Pure Bioscience Inc:

  • The MRQ is 4.414. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.275. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.414TTM3.275+1.139
TTM3.275YOY3.633-0.358
TTM3.2755Y2.426+0.849
5Y2.42610Y7.442-5.016
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4141.272+3.142
TTM3.2751.191+2.084
YOY3.6331.111+2.522
5Y2.4261.138+1.288
10Y7.4421.068+6.374

1.3. Liquidity of Pure Bioscience Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Pure Bioscience Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Household & Personal Products industry mean).
  • A Current Ratio of 1.72 means the company has $1.72 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Pure Bioscience Inc:

  • The MRQ is 1.723. The company is able to pay all its short-term debts. +1
  • The TTM is 2.366. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.723TTM2.366-0.643
TTM2.366YOY4.331-1.965
TTM2.3665Y3.120-0.754
5Y3.12010Y2.737+0.383
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7231.667+0.056
TTM2.3661.702+0.664
YOY4.3311.628+2.703
5Y3.1201.693+1.427
10Y2.7371.708+1.029
1.3.2. Quick Ratio

Measures if Pure Bioscience Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • A Quick Ratio of 0.31 means the company can pay off $0.31 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Pure Bioscience Inc:

  • The MRQ is 0.314. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.403. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.314TTM0.403-0.089
TTM0.403YOY0.352+0.051
TTM0.4035Y1.319-0.916
5Y1.31910Y1.699-0.380
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3140.759-0.445
TTM0.4030.771-0.368
YOY0.3520.779-0.427
5Y1.3190.872+0.447
10Y1.6990.933+0.766

1.4. Solvency of Pure Bioscience Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Pure Bioscience Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Pure Bioscience Inc to Household & Personal Products industry mean.
  • A Debt to Asset Ratio of 2.22 means that Pure Bioscience Inc assets are financed with 221.6% credit (debt) and the remaining percentage (100% - 221.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Pure Bioscience Inc:

  • The MRQ is 2.216. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.137. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ2.216TTM1.137+1.079
TTM1.137YOY0.190+0.947
TTM1.1375Y0.429+0.708
5Y0.42910Y0.481-0.051
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2160.448+1.768
TTM1.1370.459+0.678
YOY0.1900.463-0.273
5Y0.4290.446-0.017
10Y0.4810.448+0.033
1.4.2. Debt to Equity Ratio

Measures if Pure Bioscience Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Pure Bioscience Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.541-1.541
TTM1.541YOY0.239+1.302
TTM1.5415Y0.598+0.943
5Y0.59810Y4.045-3.447
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.787-0.787
TTM1.5410.802+0.739
YOY0.2390.789-0.550
5Y0.5980.821-0.223
10Y4.0450.841+3.204

2. Market Valuation of Pure Bioscience Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Pure Bioscience Inc generates.

  • Above 15 is considered overpriced but always compare Pure Bioscience Inc to the Household & Personal Products industry mean.
  • A PE ratio of -3.07 means the investor is paying $-3.07 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Pure Bioscience Inc:

  • The EOD is -1.954. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.070. Based on the earnings, the company is expensive. -2
  • The TTM is -2.856. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.954MRQ-3.070+1.116
MRQ-3.070TTM-2.856-0.214
TTM-2.856YOY-4.752+1.896
TTM-2.8565Y-15.102+12.246
5Y-15.10210Y13.421-28.523
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD-1.95417.607-19.561
MRQ-3.07016.299-19.369
TTM-2.85616.461-19.317
YOY-4.75220.049-24.801
5Y-15.10219.921-35.023
10Y13.42122.126-8.705
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Pure Bioscience Inc:

  • The EOD is -2.217. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.484. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.933. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.217MRQ-3.484+1.267
MRQ-3.484TTM-3.933+0.450
TTM-3.933YOY-6.378+2.444
TTM-3.9335Y-20.153+16.220
5Y-20.15310Y-16.583-3.570
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD-2.2179.316-11.533
MRQ-3.48410.067-13.551
TTM-3.93310.337-14.270
YOY-6.3785.844-12.222
5Y-20.15313.067-33.220
10Y-16.58312.684-29.267
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Pure Bioscience Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Household & Personal Products industry mean).
  • A PB ratio of -9.31 means the investor is paying $-9.31 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Pure Bioscience Inc:

  • The EOD is -5.927. Based on the equity, the company is expensive. -2
  • The MRQ is -9.314. Based on the equity, the company is expensive. -2
  • The TTM is 3.089. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD-5.927MRQ-9.314+3.387
MRQ-9.314TTM3.089-12.403
TTM3.089YOY7.806-4.717
TTM3.0895Y18.161-15.073
5Y18.16110Y197.165-179.003
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD-5.9271.512-7.439
MRQ-9.3141.711-11.025
TTM3.0891.787+1.302
YOY7.8062.000+5.806
5Y18.1612.083+16.078
10Y197.1652.813+194.352
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Pure Bioscience Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.008-0.008-10%0.000-96%-0.001-87%0.000-94%
Book Value Per Share---0.0120.000-97%0.024-150%0.020-159%0.018-166%
Current Ratio--1.7232.366-27%4.331-60%3.120-45%2.737-37%
Debt To Asset Ratio--2.2161.137+95%0.190+1067%0.429+416%0.481+361%
Debt To Equity Ratio---1.541-100%0.239-100%0.598-100%4.045-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.009-0.008-9%-0.009+1%-0.006-29%-0.012+33%
Free Cash Flow Per Share---0.008-0.006-23%-0.007-11%-0.004-45%-0.007-15%
Free Cash Flow To Equity Per Share---0.008-0.004-45%0.009-192%0.005-270%0.006-238%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.925+8%
Intrinsic Value_10Y_max---0.376--------
Intrinsic Value_10Y_min---0.321--------
Intrinsic Value_1Y_max---0.026--------
Intrinsic Value_1Y_min---0.025--------
Intrinsic Value_3Y_max---0.086--------
Intrinsic Value_3Y_min---0.082--------
Intrinsic Value_5Y_max---0.158--------
Intrinsic Value_5Y_min---0.146--------
Market Cap7829920.000-57%12304212.03010346713.110+19%18735880.000-34%46084678.622-73%72673685.431-83%
Net Profit Margin---3.074-1.990-35%-2.305-25%-1.752-43%-5.019+63%
Operating Margin----0.5370%-2.1170%-1.3500%-4.7820%
Operating Ratio--4.4143.275+35%3.633+21%2.426+82%7.442-41%
Pb Ratio-5.927+36%-9.3143.089-402%7.806-219%18.161-151%197.165-105%
Pe Ratio-1.954+36%-3.070-2.856-7%-4.752+55%-15.102+392%13.421-123%
Price Per Share0.070-57%0.1100.093+19%0.168-34%0.412-73%0.650-83%
Price To Free Cash Flow Ratio-2.217+36%-3.484-3.933+13%-6.378+83%-20.153+479%-16.583+376%
Price To Total Gains Ratio-8.347+36%-13.117-12.355-6%-14.200+8%349.800-104%172.450-108%
Quick Ratio--0.3140.403-22%0.352-11%1.319-76%1.699-82%
Return On Assets---0.923-0.574-38%-0.330-64%-0.337-63%-0.385-58%
Return On Equity----1.1230%-0.4110%-0.5440%-0.8520%
Total Gains Per Share---0.008-0.008-10%0.000-96%-0.001-87%0.000-94%
Usd Book Value---1321000.000-44250.000-97%2636000.000-150%2225550.000-159%2013325.000-166%
Usd Book Value Change Per Share---0.008-0.008-10%0.000-96%-0.001-87%0.000-94%
Usd Book Value Per Share---0.0120.000-97%0.024-150%0.020-159%0.018-166%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.009-0.008-9%-0.009+1%-0.006-29%-0.012+33%
Usd Free Cash Flow---883000.000-682000.000-23%-786500.000-11%-487300.000-45%-597375.000-32%
Usd Free Cash Flow Per Share---0.008-0.006-23%-0.007-11%-0.004-45%-0.007-15%
Usd Free Cash Flow To Equity Per Share---0.008-0.004-45%0.009-192%0.005-270%0.006-238%
Usd Market Cap7829920.000-57%12304212.03010346713.110+19%18735880.000-34%46084678.622-73%72673685.431-83%
Usd Price Per Share0.070-57%0.1100.093+19%0.168-34%0.412-73%0.650-83%
Usd Profit---1002000.000-911250.000-9%-1011500.000+1%-709800.000-29%-1331625.000+33%
Usd Revenue--326000.000514250.000-37%451000.000-28%827350.000-61%588700.000-45%
Usd Total Gains Per Share---0.008-0.008-10%0.000-96%-0.001-87%0.000-94%
 EOD+2 -6MRQTTM+6 -25YOY+7 -245Y+3 -2810Y+10 -22

3.2. Fundamental Score

Let's check the fundamental score of Pure Bioscience Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.954
Price to Book Ratio (EOD)Between0-1-5.927
Net Profit Margin (MRQ)Greater than0-3.074
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.314
Current Ratio (MRQ)Greater than11.723
Debt to Asset Ratio (MRQ)Less than12.216
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.923
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Pure Bioscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.241
Ma 20Greater thanMa 500.081
Ma 50Greater thanMa 1000.090
Ma 100Greater thanMa 2000.107
OpenGreater thanClose0.067
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2024-01-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,086
Total Liabilities2,407
Total Stockholder Equity-1,321
 As reported
Total Liabilities 2,407
Total Stockholder Equity+ -1,321
Total Assets = 1,086

Assets

Total Assets1,086
Total Current Assets939
Long-term Assets147
Total Current Assets
Cash And Cash Equivalents 557
Net Receivables 171
Inventory 74
Total Current Assets  (as reported)939
Total Current Assets  (calculated)802
+/- 137
Long-term Assets
Property Plant Equipment 147
Long-term Assets  (as reported)147
Long-term Assets  (calculated)147
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities545
Long-term Liabilities1,862
Total Stockholder Equity-1,321
Total Current Liabilities
Accounts payable 409
Total Current Liabilities  (as reported)545
Total Current Liabilities  (calculated)409
+/- 136
Long-term Liabilities
Long term Debt 1,862
Long-term Liabilities  (as reported)1,862
Long-term Liabilities  (calculated)1,862
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)-1,321
Total Stockholder Equity (calculated)0
+/- 1,321
Other
Capital Stock1,119
Common Stock Shares Outstanding 111,856
Net Debt 1,305
Net Invested Capital 541
Net Working Capital 394



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-01-312023-10-312023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-10-312017-07-312017-04-302017-01-312016-10-312016-07-312016-04-302016-01-312015-10-312015-07-312015-04-302015-01-312014-10-312014-07-312014-04-302014-01-312013-10-312013-07-312013-04-302013-01-312012-10-312012-07-312012-04-302012-01-312011-10-312011-07-312011-04-302011-01-312010-10-312010-07-312010-04-302010-01-312009-10-312009-07-312009-04-302009-01-312008-10-312008-07-312008-04-302008-01-312007-10-312007-07-312007-04-302007-01-312006-10-312006-07-312006-04-302006-01-312005-10-312005-07-312005-04-302005-01-312004-10-312004-07-312004-04-302004-01-312003-10-312003-07-312003-04-302003-01-312002-10-312002-07-312002-04-302002-01-312001-10-312001-07-312001-04-302001-01-312000-10-312000-07-312000-04-302000-01-31
> Total Assets 
4,561
5,919
4,368
4,108
3,916
3,984
4,067
3,843
5,693
5,451
4,540
4,548
4,276
3,900
3,627
5,602
5,561
5,347
5,482
5,517
5,549
3,255
3,314
2,595
3,069
8,814
7,965
7,080
6,358
5,841
4,862
11,838
11,467
11,340
10,941
9,429
7,622
6,361
7,649
8,988
7,704
7,100
5,994
7,566
5,494
3,927
5,147
4,415
4,228
4,057
4,458
5,672
4,127
3,505
2,062
3,286
2,413
2,451
1,859
7,096
5,561
4,180
3,261
7,827
8,553
7,608
7,562
6,402
6,108
4,908
3,829
5,207
3,973
2,800
2,575
2,540
1,777
1,710
1,932
2,230
1,468
4,786
6,323
5,766
5,286
4,846
4,303
3,555
2,789
2,118
4,484
3,699
2,530
1,824
1,825
2,250
1,086
1,0862,2501,8251,8242,5303,6994,4842,1182,7893,5554,3034,8465,2865,7666,3234,7861,4682,2301,9321,7101,7772,5402,5752,8003,9735,2073,8294,9086,1086,4027,5627,6088,5537,8273,2614,1805,5617,0961,8592,4512,4133,2862,0623,5054,1275,6724,4584,0574,2284,4155,1473,9275,4947,5665,9947,1007,7048,9887,6496,3617,6229,42910,94111,34011,46711,8384,8625,8416,3587,0807,9658,8143,0692,5953,3143,2555,5495,5175,4825,3475,5615,6023,6273,9004,2764,5484,5405,4515,6933,8434,0673,9843,9164,1084,3685,9194,561
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,150
0
0
0
0
0
0
0
0
895
1,031
478
5,763
4,209
2,856
1,979
6,592
7,212
6,180
6,142
4,964
4,639
3,476
2,459
3,896
2,721
1,612
1,456
1,484
793
772
1,041
1,391
633
3,996
5,566
4,880
4,115
3,718
3,197
2,453
1,740
1,110
3,864
3,072
1,940
1,230
1,604
2,066
939
9392,0661,6041,2301,9403,0723,8641,1101,7402,4533,1973,7184,1154,8805,5663,9966331,3911,0417727931,4841,4561,6122,7213,8962,4593,4764,6394,9646,1426,1807,2126,5921,9792,8564,2095,7634781,031895000000002,15000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,877
3,268
2,230
736
3,671
2,739
1,644
2,024
1,048
519
2,946
4,214
5,600
4,005
3,284
2,193
3,680
1,678
310
1,793
992
626
289
877
2,450
920
410
32
1,068
236
416
86
5,331
3,908
2,530
1,396
6,130
6,781
5,480
5,269
4,139
3,968
2,789
1,715
3,304
2,204
1,093
926
851
410
340
398
904
246
2,022
3,914
3,541
3,002
2,894
2,390
1,760
1,131
511
3,391
2,452
1,485
781
1,095
1,440
557
5571,4401,0957811,4852,4523,3915111,1311,7602,3902,8943,0023,5413,9142,0222469043983404108519261,0932,2043,3041,7152,7893,9684,1395,2695,4806,7816,1301,3962,5303,9085,331864162361,068324109202,4508772896269921,7933101,6783,6802,1933,2844,0055,6004,2142,9465191,0482,0241,6442,7393,6717362,2303,2683,877000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
707
4,759
4,823
5,891
4,608
4,081
3,548
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
75
75
75
75
75
75
75
75
75
75
75
75
75
75
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000757575757575757575757575757500000000000000000000000003,5484,0814,6085,8914,8234,759707000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
119
0
0
0
0
0
0
0
0
9
34
47
47
40
86
189
93
106
68
263
146
142
185
297
143
146
192
275
353
129
134
373
220
156
1,607
1,089
560
466
221
368
238
206
198
201
252
156
188
285
347
171
1713472851881562522011982062383682214665601,0891,6071562203731341293532751921461432971851421462636810693189864047473490000000011900000000000000000000000000000000000000000000000
       Other Current Assets 
50
59
34
102
64
40
182
177
173
187
169
303
185
91
7
3
32
0
0
0
0
65
72
52
48
60
116
55
28
0
0
23
287
140
53
22
122
102
69
30
156
178
146
76
74
190
100
189
482
432
347
80
85
110
71
231
221
194
96
154
75
33
187
150
88
312
260
331
189
154
174
175
104
52
58
71
49
75
75
75
75
75
16
46
29
35
75
75
75
75
75
75
75
75
0
0
0
0007575757575757575352946167575757575497158521041751741541893312603128815018733751549619422123171110858034743248218910019074761461781563069102122225314028723002855116604852726500003237911853031691871731771824064102345950
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,265
0
0
0
0
0
0
0
0
1,518
1,420
1,381
1,333
1,352
1,324
1,282
1,235
1,341
1,428
1,420
1,438
1,469
1,432
1,370
1,311
1,252
1,188
1,119
1,056
984
938
891
839
835
790
757
886
1,171
1,128
1,106
1,102
1,049
1,008
620
627
590
594
221
184
147
1471842215945906276201,0081,0491,1021,1061,1281,1718867577908358398919389841,0561,1191,1881,2521,3111,3701,4321,4691,4381,4201,4281,3411,2351,2821,3241,3521,3331,3811,4201,518000000002,26500000000000000000000000000000000000000000000000
       Property Plant Equipment 
1,025
1,011
1,056
1,009
967
934
903
842
790
718
614
574
526
482
433
222
197
187
167
150
134
124
152
135
126
196
353
437
407
987
969
941
954
1,038
1,035
1,010
968
906
857
823
910
862
697
625
564
495
426
357
326
291
257
226
199
171
146
127
115
42
36
28
90
97
90
83
231
407
440
495
568
574
548
530
515
487
461
443
416
388
362
333
351
328
316
465
771
747
740
769
728
697
620
627
590
594
221
184
147
147184221594590627620697728769740747771465316328351333362388416443461487515530548574568495440407231839097902836421151271461711992262572913263574264955646256978629108238579069681,0101,0351,0389549419699874074373531961261351521241341501671871972224334825265746147187908429039349671,0091,0561,0111,025
       Intangible Assets 
0
0
0
0
0
0
0
0
2,651
2,654
2,626
2,593
2,557
2,610
2,475
2,480
2,439
2,381
2,343
2,394
2,382
2,336
2,213
2,155
2,117
2,077
2,136
2,112
2,078
2,082
2,176
2,166
2,161
2,124
2,016
1,993
1,971
1,940
1,944
1,960
1,924
1,899
1,873
1,868
1,923
1,921
1,917
1,908
1,889
1,951
1,950
1,988
1,992
2,004
1,430
1,399
1,403
1,378
1,345
1,305
1,262
1,227
1,192
1,152
1,110
1,021
980
943
901
858
822
781
737
701
658
613
568
550
529
506
484
462
441
421
400
381
366
333
321
311
0
0
0
0
0
0
0
00000003113213333663814004214414624845065295505686136587017377818228589019439801,0211,1101,1521,1921,2271,2621,3051,3451,3781,4031,3991,4302,0041,9921,9881,9501,9511,8891,9081,9171,9211,9231,8681,8731,8991,9241,9601,9441,9401,9711,9932,0162,1242,1612,1662,1762,0822,0782,1122,1362,0772,1172,1552,2132,3362,3822,3942,3432,3812,4392,4802,4752,6102,5572,5932,6262,6542,65100000000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
984
938
891
839
835
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000008358398919389840000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
941
638
556
666
563
738
607
713
1,029
1,397
1,168
1,378
1,485
1,625
2,010
2,452
2,742
2,762
3,048
3,298
3,272
1,698
353
244
374
2,667
412
251
342
522
502
286
428
373
997
853
425
630
583
592
590
765
599
1,132
1,174
1,140
939
1,375
1,881
2,287
3,640
2,593
2,385
2,599
3,053
3,075
1,523
1,156
1,842
887
828
773
878
7,592
18,457
10,547
2,539
2,845
2,205
2,445
2,539
647
699
638
1,294
584
660
530
742
877
692
1,491
1,512
906
780
938
970
828
584
550
575
699
463
569
1,553
2,633
2,407
2,4072,6331,5535694636995755505848289709387809061,5121,4916928777425306605841,2946386996472,5392,4452,2052,8452,53910,54718,4577,5928787738288871,8421,1561,5233,0753,0532,5992,3852,5933,6402,2871,8811,3759391,1401,1741,1325997655905925836304258539973734282865025223422514122,6673742443531,6983,2723,2983,0482,7622,7422,4522,0101,6251,4851,3781,1681,3971,029713607738563666556638941
   > Total Current Liabilities 
941
638
556
666
563
738
607
713
1,029
1,397
1,168
778
1,485
1,625
2,010
2,406
2,742
2,719
3,003
3,250
3,215
1,652
353
244
374
319
412
251
342
522
502
276
416
359
981
836
406
610
563
573
571
748
583
1,118
1,162
1,131
934
1,373
1,870
2,284
3,637
2,590
1,170
1,539
2,153
2,332
1,513
1,156
1,829
875
817
763
869
7,584
18,450
10,542
2,536
2,842
2,192
2,433
2,528
637
682
623
1,281
572
650
523
738
877
692
1,491
1,512
906
780
938
970
828
584
550
575
699
463
569
532
806
545
5458065325694636995755505848289709387809061,5121,4916928777385236505721,2816236826372,5282,4332,1922,8422,53610,54218,4507,5848697638178751,8291,1561,5132,3322,1531,5391,1702,5903,6372,2841,8701,3739341,1311,1621,1185837485715735636104068369813594162765025223422514123193742443531,6523,2153,2503,0032,7192,7422,4062,0101,6251,4857781,1681,3971,029713607738563666556638941
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
54
10
332
10
5
4
4
6,969
17,618
9,802
1,802
1,961
1,494
1,641
1,853
0
0
0
503
0
0
0
0
0
0
0
0
0
0
239
0
0
0
0
0
0
0
0
0
0
0
0000000000023900000000005030001,8531,6411,4941,9611,8029,80217,6186,96944510332105400000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,494
1,641
1,853
0
0
0
0
0
0
0
0
0
0
0
0
0
0
239
239
239
0
0
0
0
0
0
0
0
0
000000000239239239000000000000001,8531,6411,49400000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
506
322
309
414
320
480
544
350
521
723
590
693
799
863
1,079
981
916
870
974
1,134
1,256
626
191
104
131
126
335
129
255
424
423
165
312
228
596
297
232
381
369
416
347
452
329
450
532
917
676
1,373
1,538
1,875
1,946
2,094
621
848
1,134
771
783
634
1,497
664
709
693
806
561
783
696
695
847
669
768
656
637
682
623
778
572
650
386
553
749
589
1,286
1,512
906
780
699
593
465
425
416
488
561
347
432
422
652
409
4096524224323475614884164254655936997809061,5121,2865897495533866505727786236826376567686698476956967835618066937096641,4976347837711,1348486212,0941,9461,8751,5381,3736769175324503294523474163693812322975962283121654234242551293351261311041916261,2561,1349748709169811,079863799693590723521350544480320414309322506
       Other Current Liabilities 
10
56
37
56
47
58
63
63
108
155
78
85
86
162
150
180
451
444
595
681
734
366
159
137
243
193
75
120
85
98
77
109
102
131
383
537
172
229
192
157
224
296
252
668
630
214
258
348
332
409
729
496
463
460
651
1,058
676
512
733
201
103
66
59
54
49
44
39
34
29
24
19
212
233
137
170
152
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000152170137233212192429343944495459661032017335126761,058651460463496729409332348258214630668252296224157192229172537383131102109779885120751932431371593667346815954444511801501628685781551086363584756375610
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
10
0
13
12
11
10
9
8
7
5
3
3
13
12
11
10
17
15
13
12
10
7
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,021
1,827
1,862
1,8621,8271,021000000000000000471012131517101112133357891011121301000000000200000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46
0
43
45
48
57
46
0
0
0
2,348
0
0
0
0
0
10
12
14
16
17
19
20
20
19
19
17
16
14
12
9
5
2
11
3
3
3
2
15
13
12
10
0
13
12
11
10
9
8
7
5
3
3
13
12
11
10
17
15
13
12
10
7
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000047101213151710111213335789101112130101213152333112591214161719192020191716141210000002,3480004657484543046000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
10
0
13
12
11
10
9
8
7
5
3
3
13
12
11
10
17
15
13
12
10
7
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000471012131517101112133357891011121301000000000200000000000000000000000000000000000000000000000
> Total Stockholder Equity
3,518
5,206
3,750
3,396
3,353
3,246
3,460
3,130
4,664
4,054
3,372
3,170
2,791
2,275
1,617
3,150
2,819
2,585
2,434
2,219
2,277
1,557
2,961
2,351
2,695
6,147
7,553
6,829
6,016
5,319
4,360
11,552
11,039
10,967
9,944
8,576
7,197
5,731
7,066
8,396
7,114
6,335
5,395
6,434
4,320
2,787
4,208
3,040
2,347
1,770
818
3,079
1,742
906
0
211
890
1,295
17
6,209
4,733
3,407
2,383
235
-9,904
-2,939
5,023
3,557
3,903
2,463
1,290
4,560
3,274
2,162
1,281
1,956
1,117
1,180
1,190
1,353
776
3,295
4,811
4,860
4,506
3,908
3,333
2,727
2,205
1,568
3,909
3,000
2,067
1,255
272
-383
-1,321
-1,321-3832721,2552,0673,0003,9091,5682,2052,7273,3333,9084,5064,8604,8113,2957761,3531,1901,1801,1171,9561,2812,1623,2744,5601,2902,4633,9033,5575,023-2,939-9,9042352,3833,4074,7336,209171,29589021109061,7423,0798181,7702,3473,0404,2082,7874,3206,4345,3956,3357,1148,3967,0665,7317,1978,5769,94410,96711,03911,5524,3605,3196,0166,8297,5536,1472,6952,3512,9611,5572,2772,2192,4342,5852,8193,1501,6172,2752,7913,1703,3724,0544,6643,1303,4603,2463,3533,3963,7505,2063,518
   Retained Earnings -134,982-133,980-133,245-132,213-131,337-130,277-129,284-128,051-127,291-126,589-125,793-125,060-124,249-123,654-123,474-124,796-125,269-124,603-123,478-122,659-120,786-119,490-116,924-115,540-113,848-111,821-109,482-107,636-105,898-104,962-103,219-102,540-102,570-91,668-88,848-86,982-84,891-83,155-81,221-78,546-76,49700000000-55,97100000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58,600
0
0
0
0
0
0
0
0
77,128
79,555
80,943
88,966
89,222
89,977
90,811
91,350
92,064
98,979
107,593
107,870
109,174
109,471
110,141
115,701
116,441
117,021
117,522
120,730
121,186
123,098
123,900
125,156
125,245
127,222
127,414
127,643
127,882
128,095
0
0
0
0
0
0
0
0
0
0
0
00000000000128,095127,882127,643127,414127,222125,245125,156123,900123,098121,186120,730117,522117,021116,441115,701110,141109,471109,174107,870107,59398,97992,06491,35090,81189,97789,22288,96680,94379,55577,1280000000058,60000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-07-31)

Gross Profit (+$)
totalRevenue1,877
Cost of Revenue-906
Gross Profit971971
 
Operating Income (+$)
Gross Profit971
Operating Expense-5,505
Operating Income-3,628-4,534
 
Operating Expense (+$)
Research Development297
Selling General Administrative4,302
Selling And Marketing Expenses0
Operating Expense5,5054,599
 
Net Interest Income (+$)
Interest Income0
Interest Expense-14
Other Finance Cost-0
Net Interest Income-14
 
Pretax Income (+$)
Operating Income-3,628
Net Interest Income-14
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,961-3,309
EBIT - interestExpense = -14
-3,961
-3,947
Interest Expense14
Earnings Before Interest and Taxes (EBIT)0-3,947
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-3,961
Tax Provision-0
Net Income From Continuing Ops-3,961-3,961
Net Income-3,961
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-31914
 

Technical Analysis of Pure Bioscience Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Pure Bioscience Inc. The general trend of Pure Bioscience Inc is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Pure Bioscience Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Pure Bioscience Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.07 < 0.07 < 0.07.

The bearish price targets are: 0.06.

Tweet this
Pure Bioscience Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Pure Bioscience Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Pure Bioscience Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Pure Bioscience Inc. The current macd is -0.0053706.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Pure Bioscience Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Pure Bioscience Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Pure Bioscience Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Pure Bioscience Inc Daily Moving Average Convergence/Divergence (MACD) ChartPure Bioscience Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Pure Bioscience Inc. The current adx is 23.34.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Pure Bioscience Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Pure Bioscience Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Pure Bioscience Inc. The current sar is 0.08182864.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Pure Bioscience Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Pure Bioscience Inc. The current rsi is 40.24. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Pure Bioscience Inc Daily Relative Strength Index (RSI) ChartPure Bioscience Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Pure Bioscience Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Pure Bioscience Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Pure Bioscience Inc Daily Stochastic Oscillator ChartPure Bioscience Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Pure Bioscience Inc. The current cci is -124.72647702.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Pure Bioscience Inc Daily Commodity Channel Index (CCI) ChartPure Bioscience Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Pure Bioscience Inc. The current cmo is -23.2649023.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Pure Bioscience Inc Daily Chande Momentum Oscillator (CMO) ChartPure Bioscience Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Pure Bioscience Inc. The current willr is -66.66666667.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Pure Bioscience Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Pure Bioscience Inc Daily Williams %R ChartPure Bioscience Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Pure Bioscience Inc.

Pure Bioscience Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Pure Bioscience Inc. The current atr is 0.00868952.

Pure Bioscience Inc Daily Average True Range (ATR) ChartPure Bioscience Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Pure Bioscience Inc. The current obv is -3,161,294.

Pure Bioscience Inc Daily On-Balance Volume (OBV) ChartPure Bioscience Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Pure Bioscience Inc. The current mfi is 24.53.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Pure Bioscience Inc Daily Money Flow Index (MFI) ChartPure Bioscience Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Pure Bioscience Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Pure Bioscience Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Pure Bioscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.241
Ma 20Greater thanMa 500.081
Ma 50Greater thanMa 1000.090
Ma 100Greater thanMa 2000.107
OpenGreater thanClose0.067
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Pure Bioscience Inc with someone you think should read this too:
  • Are you bullish or bearish on Pure Bioscience Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Pure Bioscience Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Pure Bioscience Inc

I send you an email if I find something interesting about Pure Bioscience Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Pure Bioscience Inc.

Receive notifications about Pure Bioscience Inc in your mailbox!